Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PBM
Pharma
Amgen will delay buyout of Horizon, complying with FTC request
Amgen has agreed not to close its proposed $27.8 billion deal to acquire Horizon Therapeutics until September. The move comes after an FTC lawsuit.
Kevin Dunleavy
May 19, 2023 11:05am
Senate advances basket of drug pricing bills
May 12, 2023 10:40am
PhRMA attacks PBMs for limiting patient access to medicines
May 3, 2023 9:20am
Novartis CEO outlines post-IRA priorities for pharma industry
Feb 1, 2023 2:52pm
Sanofi, Lilly and Novo must face RICO claims over insulin costs
Jul 13, 2021 12:23pm
PBMs' new ads focus on drug price negotiations
Feb 27, 2019 11:01am